The earliest study in cancer cells showed that the small interfering RNA (siRNA)-mediated partial knockdown of HSPA2 significantly reduced growth and produced a distinct phenotype from that caused by the HSPA1A/B knockdown, thus pointing to a possible functional diversity between HSPA1 and HSPA2 [26]. This evidence concerns the gene HSPA1A and cancer.